Negative symptoms in first-episode psychosis: Clinical correlates and 1-year follow-up outcomes in London Early Intervention Services

被引:25
|
作者
Rammou, Aikaterini [1 ,2 ]
Fisher, Helen L. [1 ]
Johnson, Sonia [3 ,4 ]
Major, Barnaby [5 ,6 ]
Rahaman, Nikola [7 ]
Chamberlain-Kent, Nick [8 ]
Stone, James M. [1 ,9 ]
机构
[1] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England
[2] Univ Sussex, Sch Psychol, Brighton, E Sussex, England
[3] UCL, Div Psychiat, London, England
[4] Camden & Islington NHS Fdn Trust, London, England
[5] East London NHS Fdn Trust, EQUIP, London, England
[6] 2gether NHS Fdn Trust, Herefordshire Early Intervent Serv, Hereford, England
[7] Cent & North West London NHS Fdn Trust, Kensington Chelsea Westminster & Brent Early Inte, London, England
[8] South West London & St Georges Mental Hlth NHS Tr, Wandsworth Early Intervent Serv, London, England
[9] South London & Maudsley NHS Fdn Trust, London, England
关键词
early intervention; first episode; negative symptoms; psychosis; schizophrenia; ULTRA-HIGH RISK; COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED MULTICENTER TRIAL; 1ST EPISODE SCHIZOPHRENIA; GENDER-DIFFERENCES; STANDARD TREATMENT; SUICIDAL-BEHAVIOR; SUBSTANCE MISUSE; CANNABIS USE; PREDICTORS;
D O I
10.1111/eip.12502
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Aim Negative symptoms (NS) have been associated with poor outcome and remain difficult to treat in patients with psychosis. This study examined the association of NS with clinical features at first presentation to mental health services for psychosis and with outcomes at 1-year follow-up. Methods Clinical data were utilized from five London Early Intervention Services (EIS) included in the MiData audit database. The sample comprised 484 first-episode psychosis patients with complete Positive and Negative Syndrome Scale data at baseline and 1-year follow-up. Multiple imputation (N = 50) was conducted to account for missing follow-up data. Results Baseline NS were associated with male gender (B = -1.63, P < .05), younger age at onset (B = -.15, P <. 05), a higher level of impairment on the Global Assessment of Functioning (disability) Scale at baseline (B = -.19, P <. 010), an absence of reported substance misuse prior to baseline assessment (B = -3.05, P <. 001) and unemployment at baseline (B = -.93, P <. 01). At 1-year follow-up, NS at presentation were associated with worse Global Assessment of Functioning Scale for symptom (B = -.28, P < .01) and disability (B = -.27, P <. 05) and with hospital admission (OR = 1.06, P < .01). Conclusions Negative symptoms at presentation to EIS were associated with worse functioning at entry and poorer outcomes 1 year later. Future research is required to better understand the aetiology and trajectories of NS in early psychosis and propose novel targeted interventions.
引用
收藏
页码:443 / 452
页数:10
相关论文
共 50 条
  • [21] Early detection of first-episode psychosis: The effect on 1-year outcome
    Larsen, Tor K.
    Melle, Ingrid
    Auestad, Bjorn
    Friis, Svein
    Haahr, Ulrik
    Johannessen, Jan Olav
    Opjordsmoen, Stein
    Rund, Bjorn Rishovd
    Simonsen, Erik
    Vaglum, Per
    McGlashan, Thomas
    SCHIZOPHRENIA BULLETIN, 2006, 32 (04) : 758 - 764
  • [22] Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial
    Clausen, L.
    Hjorthoj, C. R.
    Thorup, A.
    Jeppesen, P.
    Petersen, L.
    Bertelsen, M.
    Nordentoft, M.
    PSYCHOLOGICAL MEDICINE, 2014, 44 (01) : 117 - 126
  • [23] Insight in early psychosis: a 1-year follow-up
    Mintz, AR
    Addington, J
    Addington, D
    SCHIZOPHRENIA RESEARCH, 2004, 67 (2-3) : 213 - 217
  • [24] Bioenergetic markers in cerebrospinal fluid in first-episode psychosis: Are they predictors of early antipsychotic response and 1-year outcomes?
    Gine-Serven, Eloi
    Boix-Quintana, Ester
    Ballesteros, Alejandro
    Davi-Loscos, Eva
    Guanyabens, Nicolau
    Casado, Virginia
    Martinez-Ramirez, Maria
    Crespo-Facorro, Benedicto
    Cuesta, Manuel J.
    Labad, Javier
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2025, 138
  • [25] Examining disorganization in patients with first episode psychosis: Findings from a 1-year follow-up of the 'Parma early psychosis' program
    Pelizza, Lorenzo
    Leuci, Emanuela
    Maestri, Davide
    Quattrone, Emanuela
    Azzali, Silvia
    Paulillo, Giuseppina
    Pellegrini, Pietro
    EARLY INTERVENTION IN PSYCHIATRY, 2022, 16 (05) : 552 - 560
  • [26] Resting-state functional connectivity of the striatum predicts improvement in negative symptoms and general functioning in patients with first-episode psychosis: A 1-year naturalistic follow-up study
    Oh, Sanghoon
    Kim, Minah
    Kim, Taekwan
    Lee, Tae Young
    Kwon, Jun Soo
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2020, 54 (05): : 509 - 518
  • [27] Cost-effectiveness of treating first-episode psychosis: five-year follow-up results from an Italian early intervention programme
    Angelo, Cocchi
    Vittorio, Mapelli
    Anna, Meneghelli
    Antonio, Preti
    EARLY INTERVENTION IN PSYCHIATRY, 2011, 5 (03) : 203 - 211
  • [28] Predictors of Relapse and Functioning in First-Episode Psychosis: A Two-Year Follow-Up Study
    Berge, Daniel
    Mane, Anna
    Salgado, Purificacion
    Cortizo, Romina
    Garnier, Carolina
    Gomez, Laura
    Diez-Aja, Cristobal
    Bulbena, Antoni
    Perez, Victor
    PSYCHIATRIC SERVICES, 2016, 67 (02) : 227 - 233
  • [29] Predicting prognosis in patients with first-episode psychosis using auditory P300: A 1-year follow-up study
    Lho, Silvia Kyungjin
    Kim, Minah
    Lee, Tak Hyung
    Bin Kwak, Yoo
    Kwon, Jun Soo
    CLINICAL NEUROPHYSIOLOGY, 2019, 130 (01) : 46 - 54
  • [30] Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis
    Saiz-Masvidal, Cristina
    Contreras, Fernando
    Soriano-Mas, Carles
    Mezquida, Gisela
    Diaz-Caneja, Covadonga M.
    Vieta, Eduard
    Amoretti, Silvia
    Lobo, Antonio
    Gonzalez-Pinto, Ana
    Janssen, Joost
    Sague-Vilavella, Maria
    Castro-Fornieles, Josefina
    Berge, Daniel
    Bioque, Miquel
    Lois, Noemi G.
    Parellada, Mara
    Bernardo, Miguel
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2023, 120